2009China Modern DoctorRequires access

Clinical Observation of Alprostrodil's Treatment for Unstable Angina Pectoris

Meng He

Open publisher page 0 citations

Abstract

Objective To observe clinical efficacy of Alprostrodil's treatment for unstable angina pectoris. Methods Conventional treatment is used for the control group;in addition to conventional treatment,intravenous drip of 200ml glucose(diabetes use saline) with 10μg Alprostrodil is used for treatment group once a day. Results The treatment group,compared with control group,the occurrence of unstable angina pectoris is reduced,and the treatment group is better than control group(P0.05) ;the time of unstable angina pectoris attack is reduced,and the treatment group is better than control group(P0.01) . NST,∑ST in the treatment group is less than that in control group,so clinical symptoms are improved,and the treatment group is better than control group(P0.05) in ERG changes. Conclusion Alprostadil injection can control unstable angina pectoris effectively and improve myocardial ischemia.

About this research paper

What this paper is about

Objective To observe clinical efficacy of Alprostrodil's treatment for unstable angina pectoris. Methods Conventional treatment is used for the control group;in addition to conventional treatment,intravenous drip of 200ml glucose(diabetes use saline) with 10μg Alprostrodil is used for treatment group once a day. Results The treatment group,compared with control group,the occurrence of unstable angina pectoris is reduced,and the treatment group is better than control group(P0.05) ;the time of unstable angina pectoris attack is reduced,and the treatment group is better than control group(P0.01) . NST,∑ST in the treatment group is less than that in control group,so clinical symptoms are improved,and the treatment group is better than control group(P0.05) in ERG changes. Conclusion Alprostadil injection can control unstable angina pectoris effectively and improve myocardial ischemia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe clinical efficacy of Alprostrodil's treatment for unstable angina pectoris. Methods Conventional treatment is used for the control group;in addition to conventional treatment,intravenous drip of 200ml glucose(diabetes use saline) with 10μg Alprostrodil is used for treatment group once a day. Results The treatment group,compared with control group,the occurrence of unstable angina pectoris is reduced,and the treatment group is better than control group(P0.05) ;the time of unstable angina pectoris attack is reduced,and the treatment group is better than control group(P0.01) . NST,∑ST in the treatment group is less than that in control group,so clinical symptoms are improved,and the treatment group is better than control group(P0.05) in ERG changes. Conclusion Alprostadil injection can control unstable angina pectoris effectively and improve myocardial ischemia.

Key concepts: Medicine, Unstable angina, Angina, Treatment and control groups, Saline, Conventional treatment, Clinical efficacy, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Observation of Alprostrodil's Treatment for Unstable Angina Pectoris — Research Paper | ScholarLens